Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
复制标题
I 期上皮性卵巢癌患者的肿瘤生育能力:年轻育龄女性的生育力保留手术
DOI:
10.1186/s12957-017-1222-4
复制
发表时间:
2017-08-15
影响因子:
3.2
通讯作者:
Shen K
中科院分区:
文献类型:
--
作者:
Jiang X;Yang J;Yu M;Xie W;Cao D;Wu M;Pan L;Huang H;You Y;Shen K
Fertility-sparing surgery is indicated for patients with stage I epithelial ovarian cancers. We sought to evaluate the clinical outcomes and oncofertility in a cohort of patients of reproductive age with stage I epithelial ovarian cancer (EOC). Overall, 108 patients of reproductive age (≤ 40 years) diagnosed with stage I EOC who were treated at Peking Union Medical College Hospital between 1999 and 2013 were included in the study. The Kaplan-Meier model and Cox regression analyses were used for the survival analysis. The type of surgery included fertility-sparing surgery (FSS) (48.1%) and radical surgery (RS) (51.9%). After a median follow-up of 83 months, we observed that grade 3 or clear-cell carcinoma was the only independent risk factor for disease-free survival and tumor-specific survival in the multivariate analysis. Patients with grade 3 or clear-cell carcinoma tended to be older than 30 years, have endometriosis, and undergo RS (p < 0.05). Fertility-sparing surgery did not affect disease-free survival or tumor-specific survival among patients of reproductive age with stage I EOC and among high-risk patients with stage IC2-3, grade 3, or clear-cell carcinoma. Thirty-four out of 52 (65.4%) FSS patients attempted to get pregnant. Twenty-eight (82.4%) achieved a successful pregnancy with a full-term delivery. Grade 3 or clear-cell carcinoma was the only independent risk factor for survival of patients of reproductive age with stage I EOC. FSS can be safely performed on patients of reproductive age with grade 1-2, stage I EOC. The safety of FSS for grade 3 and clear-cell carcinoma warrants further investigation.
登录
查看更多内容
影响因子:
3.3
作者:
Kajiyama, Hiroaki;Mizuno, Mika;Kikkawa, Fumitaka
通讯作者:
Kikkawa, Fumitaka
影响因子:
50.5
作者:
Fruscio, R.;Corso, S.;Colombo, N.
通讯作者:
Colombo, N.
影响因子:
9.8
作者:
Wang, Miaomiao;Chu, Haiyan;Zhang, Zhengdong
通讯作者:
Zhang, Zhengdong
影响因子:
6.7
作者:
Ye, Shuang;Yang, Jiaxin;Shen, Keng
通讯作者:
Shen, Keng
影响因子:
3.7
作者:
Marpeau, Olivier;Schilder, Jeanne;Morice, Philippe
通讯作者:
Morice, Philippe